Header Logo

Connection

Barbara Swanson to Anticholesteremic Agents

This is a "connection" page, showing publications Barbara Swanson has written about Anticholesteremic Agents.
Connection Strength

0.396
  1. Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Altern Ther Health Med. 2011 Mar-Apr; 17(2):30-5.
    View in: PubMed
    Score: 0.396
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.